Last reviewed · How we verify
Bronchospasm Prevention
Approved treatments
- Proventil · Merck & Co.
- Intal · Pfizer
- ProAir · Generic (originally Allen & Hanburys/GSK)
Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm. - Cromoglicate · LEO Pharma
- Levalbuterol · University of Aleppo
Levalbuterol activates beta 2 -adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscles. - Xopenex · Oak Pharms Inc
Xopenex works by activating the beta-2 adrenergic receptor, leading to bronchodilation and relaxation of airway smooth muscle. - Metaproterenol
- Brethine
- Tornalate · Sanofi
- xopenex · Phoenix Children's Hospital
- Cromoglycate · Vishwajit Nimgaonkar, MD PhD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bronchospasm Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Bronchospasm Prevention treatment landscape brief
- Bronchospasm Prevention treatment updates RSS
Frequently asked questions about Bronchospasm Prevention
What drugs treat Bronchospasm Prevention?
Tracked treatments include Proventil, Intal, ProAir, Cromoglicate, Levalbuterol, Xopenex, Metaproterenol, Brethine.
What is the treatment for Bronchospasm Prevention?
Standard treatment for Bronchospasm Prevention includes Proventil, Intal, ProAir, Cromoglicate, Levalbuterol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bronchospasm Prevention patent cliff · Bronchospasm Prevention CI report
- Treatment: Proventil · Merck & Co.
- Treatment: Intal · Pfizer
- Treatment: ProAir · Generic (originally Allen & Hanburys/GSK)
- Treatment: Cromoglicate · LEO Pharma
- Treatment: Levalbuterol · University of Aleppo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing